Charles Schwab Investment Management Inc Chemo Centryx, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$22.17 - $51.8 $1.67 Million - $3.91 Million	75,528 Added 19.76%	457,772 $23.6 Million
Q2 2022 Aug 15, 2022	BUY	$15.36 - $27.51 $223,411 - $400,132	14,545 Added 3.96%	382,244 $9.47 Million
Q1 2022 May 13, 2022	BUY	$22.22 - $39.12 $192,269 - $338,505	8,653 Added 2.41%	367,699 $9.22 Million
Q4 2021 Feb 11, 2022	BUY	$18.38 - $40.5 $599,426 - $1.32 Million	32,613 Added 9.99%	359,046 $13.1 Million
Q3 2021 Nov 16, 2021	SELL	$13.18 - $19.83 $351,971 - $529,560	-26,705 Reduced 7.56%	326,433 $5.58 Million
Q2 2021 Aug 16, 2021	SELL	$9.59 - $50.88 $206,472 - $1.1 Million	-21,530 Reduced 5.75%	353,138 $4.73 Million
Q1 2021 May 17, 2021	BUY	$49.53 - $68.4 $448,939 - $619,977	9,064 Added 2.48%	374,668 $19.2 Million
Q4 2020 Feb 16, 2021	BUY	$47.25 - $65.16 $77,962 - $107,514	1,650 Added 0.45%	365,604 $22.6 Million
Q3 2020 Nov 13, 2020	BUY	$46.35 - $61.69 $11.6 Million - $15.4 Million	250,259 Added 220.11%	363,954 $19.9 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $65.07 $409,410 - $690,522	10,612 Added 10.29%	113,695 $6.54 Million
Q1 2020 May 15, 2020	BUY	$32.73 - $50.78 $90,760 - $140,812	2,773 Added 2.76%	103,083 $4.14 Million
Q4 2019 Feb 07, 2020	BUY	$6.81 - $39.55 $24,624 - $143,012	3,616 Added 3.74%	100,310 $3.97 Million
Q3 2019 Nov 08, 2019	SELL	$6.47 - $8.96 $296,765 - $410,977	-45,868 Reduced 32.17%	96,694 $656,000
Q2 2019 Aug 09, 2019	BUY	$8.31 - $14.85 $776,029 - $1.39 Million	93,385 Added 189.9%	142,562 $1.33 Million
Q2 2018 Aug 08, 2018	BUY	$10.62 - $13.98 $64,537 - $84,956	6,077 Added 14.1%	49,177 $648,000
Q1 2018 May 07, 2018	BUY	$5.9 - $14.99 $46,610 - $118,421	7,900 Added 22.44%	43,100 $587,000
Q3 2017 Nov 13, 2017	BUY	$6.5 - $10.69 $228,800 - $376,288	35,200	35,200 $262,000

Others Institutions Holding CCXI

# of Institutions

Shares Held

66.3K

Call Options Held

Put Options Held

View Full List

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account